– Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study –– Company expects to submit New Drug Application (NDA) […]
HOUSTON, March 14, 2025 (GLOBE NEWSWIRE) — MRC Global Inc. (NYSE: MRC) today reported full year and fourth quarter 2024 results. Full Year 2024 Financial […]
MIAMI BEACH, Fla., March 14, 2025 (GLOBE NEWSWIRE) — AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of […]